Religare Enterprises Limited (IN:RELIGARE)
:RELIGARE
Want to see IN:RELIGARE full AI Analyst Report?
Top Page
Religare Enterprises Limited
(RELIGARE)
Select Model
Select Model
Rating:57Neutral
Price Target:
₹288.00
▲(15.52% Upside)
Action:Reiterated
Date:05/18/26
The score is primarily supported by improving financial health and strong cash generation, but is held back by volatile profitability (including negative operating profit in FY2026). Technicals are mixed with the stock below longer-term averages, and valuation is penalized by a negative P/E and lack of dividend yield data.
Positive Factors
Strong cash generation
Operating and free cash flow were substantial and FCF surged in FY2026 versus FY2025. Reliable cash generation supports internal funding of growth, reduces refinancing risk, and provides a durable liquidity buffer that helps the firm withstand earnings volatility.
Negative Factors
Negative operating profit (FY2026)
Operating profit moved to negative in FY2026 after prior positive years, signaling deterioration in core profitability or one-off pressures. Sustained negative operating results undermine earnings quality, constrain reinvestment capacity, and raise risk that cash generation may not be durable.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Operating and free cash flow were substantial and FCF surged in FY2026 versus FY2025. Reliable cash generation supports internal funding of growth, reduces refinancing risk, and provides a durable liquidity buffer that helps the firm withstand earnings volatility.
Read all positive factors
Religare Enterprises Limited (RELIGARE) vs. iShares MSCI India ETF (INDA)
Market Cap
₹91.41B
Dividend YieldN/A
Average Volume (3M)55.94K
Price to Earnings (P/E)106.4
Beta (1Y)0.48
Revenue Growth13.85%
EPS Growth-31.56%
CountryIN
Employees13,000
SectorFinancial
Sector Strength70
IndustryFinancial - Diversified
Share Statistics
EPS (TTM)3.18
Shares Outstanding332,890,470
10 Day Avg. Volume70,962
30 Day Avg. Volume55,941
Financial Highlights & Ratios
PEG Ratio-2.47
Price to Book (P/B)2.31
Price to Sales (P/S)0.80
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Religare Enterprises Limited Business Overview & Revenue Model
Company Description
Religare Enterprises Limited functions as an investment holding company, conducting operations across India and globally. The firm provides a broad spectrum of financial and ancillary services, including brokerage for equities, currencies, and com...
How the Company Makes Money
null...
Religare Enterprises Limited Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
64
Positive
Cash Flow
78
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.06B | 84.31B | 73.18B | 61.91B | 43.19B | 31.89B |
| Gross Profit | 55.88B | 67.52B | 48.64B | 40.74B | 36.93B | 24.49B |
| EBITDA | 2.23B | 1.34B | 3.39B | 6.10B | 39.41B | -2.38B |
| Net Income | 1.05B | 859.58M | 1.25B | 2.33B | 869.31M | -15.44B |
Balance Sheet | ||||||
| Total Assets | 125.05B | 145.06B | 112.29B | 95.77B | 80.94B | 93.53B |
| Cash, Cash Equivalents and Short-Term Investments | 10.26B | 17.03B | 10.87B | 10.72B | 7.98B | 25.26B |
| Total Debt | 3.19B | 4.93B | 2.33B | 4.43B | 8.41B | 49.37B |
| Total Liabilities | 85.56B | 106.28B | 77.92B | 64.08B | 54.16B | 98.85B |
| Stockholders Equity | 29.06B | 29.08B | 25.16B | 23.43B | 20.58B | -9.82B |
Cash Flow | ||||||
| Free Cash Flow | 2.47B | 25.80B | 15.47B | 14.78B | 14.66B | 15.56B |
| Operating Cash Flow | 2.55B | 25.93B | 15.72B | 15.00B | 15.06B | 15.96B |
| Investing Cash Flow | -8.46B | -29.04B | -11.85B | -13.48B | -9.39B | -6.89B |
| Financing Cash Flow | 5.11B | 6.45B | -2.85B | -1.56B | -20.79B | 5.59B |
Religare Enterprises Limited Technical Analysis
Positive
249.30
Price Trends
232.07
Positive
228.79
Positive
239.12
Positive
Market Momentum
10.24
Negative
82.50
Negative
94.06
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RELIGARE, the sentiment is Positive. The current price of 249.3 is above the 20-day moving average (MA) of 241.99, above the 50-day MA of 232.07, and above the 200-day MA of 239.12, indicating a bullish trend. The MACD of 10.24 indicates Negative momentum. The RSI at 82.50 is Negative, neither overbought nor oversold. The STOCH value of 94.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:RELIGARE.
Religare Enterprises Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹306.11B | 4.85 | ― | 1.88% | -1.82% | -22.53% | |
68 Neutral | ₹106.23B | 18.83 | ― | ― | -4.69% | -21.54% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | ₹120.42B | 10.01 | ― | 2.93% | -4.32% | 46.29% | |
61 Neutral | ₹568.97B | 30.36 | ― | 0.57% | 12.44% | -25.55% | |
57 Neutral | ₹91.41B | 106.37 | ― | ― | 13.85% | -31.56% | |
56 Neutral | ₹115.86B | 16.96 | ― | 1.37% | 14.15% | 43.84% |
* Financial Sector Average
IN:RELIGARE
Religare Enterprises Limited
274.60
50.40
22.48%
IN:ANGELONE
Angel One Limited
335.15
49.49
17.32%
IN:EDELWEISS
Edelweiss Financial Services Limited
122.40
14.58
13.52%
IN:IIFLCAPS
IIFL Capital Services Ltd
340.85
2.11
0.62%
IN:JMFINANCIL
JM Financial Limited
125.90
-26.19
-17.22%
IN:MOTILALOFS
Motilal Oswal Financial Services Limited
944.90
92.83
10.89%
Religare Enterprises Limited Corporate Events
Religare Housing Finance arm appoints Pavan Kumar Gupta as MD & CEO
Jun 25, 2026
Religare Enterprises Limited has announced that the board of its step-down subsidiary, Religare Housing Development Finance Corporation Limited, has appointed industry veteran Pavan Kumar Gupta as Managing Director and Chief Executive Officer, eff...
Exchange Seeks Clarification from Religare on March 2026 Quarterly Results
May 22, 2026
Religare Enterprises Limited has received a query from the stock exchange regarding its financial results for the quarter ended 31 March 2026 under Regulation 33 of SEBI’s Listing Obligations and Disclosure Requirements. The company has yet ...
Religare Enterprises Releases Investor Presentation Ahead of FY2026 Earnings Call
May 12, 2026
Religare Enterprises Limited has released an investor presentation ahead of its earnings call scheduled for May 13, 2026, to discuss the operational and financial performance for the quarter and full year ended March 31, 2026. The presentation has...
Religare Elevates CFO Pankaj Rathi to Executive Director at Housing Finance Arm
May 8, 2026
Religare Housing Development Finance Corporation Limited, a step-down subsidiary of Religare Enterprises, has elevated its Chief Financial Officer, Pankaj Rathi, to the role of Additional Director and Whole-Time Director, designated as Executive D...
Religare’s Care Health Insurance names Ajay Kumar Shah MD & CEO
Apr 26, 2026
Religare Enterprises has announced that its material subsidiary Care Health Insurance Limited has appointed Ajay Kumar Shah as Managing Director and CEO for a five-year term starting April 26, 2026, following board and committee approval and subje...
Religare Elevates Manish Dodeja to Whole-Time Director at Care Health Insurance
Apr 26, 2026
Religare Enterprises has announced that the board of its material subsidiary, Care Health Insurance Limited, has appointed Manish Vishnu Dodeja as Whole-time Director, designated as Executive Director, for a five-year term starting April 26, 2026,...
Religare announces end of Care Health Insurance CEO Anuj Gulati’s tenure
Apr 26, 2026
Religare Enterprises has announced that the tenure of Mr. Anuj Gulati as Managing Director and CEO of its material subsidiary Care Health Insurance Limited ended at the close of business on April 25, 2026. The board formally recorded its appreciat...
Religare Publishes EGM Notices, Confirms May 5 Virtual Meeting
Apr 11, 2026
Religare Enterprises Limited has notified the stock exchanges that it has published newspaper advertisements regarding its upcoming Extra-Ordinary General Meeting to be held on May 5, 2026 at 11:00 a.m. IST. The meeting will be conducted through v...
Religare calls May 5 EGM to seek shareholder nod to shift registered office to Haryana
Apr 11, 2026
Religare Enterprises Limited has called an Extraordinary General Meeting of shareholders for May 5, 2026, to be held via video conferencing and other audio-visual means, with remote e-voting and e-voting facilities provided through KFin Technologi...
Religare Grants 22,692 Stock Options Under ESOP 2019
Mar 30, 2026
Religare Enterprises Limited has granted 22,692 stock options under its Employee Stock Option Plan 2019 to eligible employees, in line with SEBI’s share-based employee benefits regulations. Each option is convertible into one equity share wi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.